ZIMMER BIOMET HOLDINGS, INC. Cash and Cash Equivalents
ZIMMER BIOMET HOLDINGS, INC. (ZBH) had Cash and Cash Equivalents of $410.00 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $410.00M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $424.20M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $591.90M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.29B.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $410.00M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $424.20M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $591.90M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $1.29B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $556.90M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.38B 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $525.50M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $569.00M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $420.10M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $393.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $415.80M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $292.10M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $319.80M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $330.20M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $375.70M 8-K · filed 2024-08-07 | |
| 2022-09-30 | $545.40M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $386.40M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $435.80M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $378.10M 10-K · filed 2023-02-24 | $478.50M 10-K · filed 2022-02-25 |
| 2021-09-30 | $919.60M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.04B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $724.30M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $774.70M 8-K · filed 2022-06-22 | $802.10M 10-K · filed 2021-02-22 |
| 2020-09-30 | $967.30M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $713.40M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.43B 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $617.90M 10-K · filed 2021-02-22 | |
| 2019-09-30 | $512.50M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $403.10M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $586.80M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $542.80M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $524.60M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $481.20M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.77B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $524.40M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $480.80M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $450.00M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.04B 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $634.10M 10-Q · filed 2018-05-08 | |
| 2016-09-30 | $475.30M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $976.30M 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $996.80M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $1.46B 10-K · filed 2018-02-27 | |
| 2015-09-30 | $1.47B 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $1.42B 10-Q · filed 2016-08-08 | |
| 2015-03-31 | $8.79B 10-Q · filed 2016-05-10 | |
| 2014-12-31 | $1.08B 10-K · filed 2018-02-27 | |
| 2014-09-30 | $967.30M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $968.70M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $882.70M 10-Q · filed 2015-05-07 | |
| 2013-12-31 | $1.08B 10-K · filed 2017-03-01 | |
| 2013-09-30 | $917.40M 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $709.90M 10-Q · filed 2014-08-07 | |
| 2013-03-31 | $657.00M 10-Q · filed 2014-05-06 | |
| 2012-12-31 | $884.30M 10-K · filed 2016-02-29 | |
| 2012-09-30 | $801.50M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $651.00M 10-Q · filed 2013-08-07 | |
| 2012-03-31 | $674.00M 10-Q · filed 2013-05-08 | |
| 2011-12-31 | $768.30M 10-K · filed 2015-02-23 | |
| 2011-09-30 | $553.00M 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $624.10M 10-Q · filed 2012-08-07 | |
| 2011-03-31 | $575.60M 10-Q · filed 2012-05-03 | |
| 2010-12-31 | $668.90M 10-K · filed 2014-02-28 | |
| 2010-09-30 | $918.60M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $953.70M 10-Q · filed 2011-08-08 | |
| 2010-03-31 | $821.20M 10-Q · filed 2011-05-05 | |
| 2009-12-31 | $691.70M 10-K · filed 2013-02-27 | |
| 2009-09-30 | $439.70M 10-Q · filed 2010-11-03 | |
| 2009-06-30 | $277.50M 10-Q · filed 2010-08-05 | |
| 2009-03-31 | $212.80M 10-Q · filed 2010-05-05 | |
| 2008-12-31 | $212.60M 10-K · filed 2012-02-27 | |
| 2008-09-30 | $542.40M 10-Q · filed 2009-11-04 | |
| 2008-06-30 | $388.10M 10-Q/A · filed 2009-08-17 | |
| 2007-12-31 | $463.90M 10-K · filed 2011-02-25 | |
| 2006-12-31 | $265.70M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |